Rewards
All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Trending on Bing
Chevron decision overturned
Jan. 6 riot obstruction ruling
SCOTUS homeless decision
Sues OpenAI, Microsoft
Sentenced to life in prison
Mammoths death mystery
US sends assault ship
Mich. woman to stand trial
New duet 'Cowboys Cry Too'
5 takeaways from debate
Monolith appears in Colo.
Premium adds new features
Recalls working w/ Andrews
Joins 'Dexter' prequel
MN judge reprimanded
Donates record $5.3 billion
7 hikers hospitalized
US service member charged
Condemns racist abuse
Oakland firefighter drowns
Ex-Uvalde chief arrested
Princess Anne discharged
Wildfire prompts evacuation
Pocket watch returns home
Patriot systems to UKR?
Gaza aid peer review
US to confront Russia at UN
Wins Hart, Lindsay awards
New hearing in docs case
Fourth of July travel rush
Baseus power banks recalled
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ozempic, Novo Nordisk
Ozempic craze: Novo Nordisk invests $4.1B in US to expand manufacturing
Novo Nordisk is investing $4.1 billion to expand its U.S. manufacturing capacity to address the growing demand for its highly sought-after weight-loss-related drugs. The Danish pharmaceutical manufacturer will also boost its current production investment this year to $6.
Wegovy-maker Novo Nordisk to spend $4.1 bln to boost US manufacturing
Obesity drug-maker Novo Nordisk will spend $4.1 billion to build a U.S. facility to fill injection pens for its hugely popular weight-loss treatment Wegovy and diabetes drug Ozempic, it said on Monday.
Ozempic maker Novo Nordisk to spend $4.1 billion to boost production
Novo Nordisk on Monday said it will invest $4.1 billion in a new Clayton, N.C., manufacturing facility as it works to meet surging demand for its
The Financial Times
4d
Novo Nordisk invests $4bn to expand weight loss drug production in US
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
Novo
Nordisk
is investing $4.1bn ...
pharmaphorum
4d
Novo Nordisk pledges $4.1bn for US injectables plant
Novo
Nordisk
has gone up another gear in its drive
to boost
manufacturing
capacity for its fast-growing GLP-1 agonist ...
Benzinga.com on MSN
3d
Wegovy, Ozempic Maker Novo Nordisk To Invest $4.1B In US Manufacturing, Doubling Plant Size To Meet Surging Demand For Weight Loss Drugs
Novo
Nordisk
A/S NVO is set to invest $4.1 billion in expanding its
U.S
.
manufacturing
operations to meet the ...
The Business Journals
1d
Surging demand for Ozempic, Wegovy fuels Novo Nordisk's expansion in NC
Demand for its weight-loss and diabetes drugs is fueling
Novo
Nordisk
's 1,000-job facility in Clayton.
Novo
Nordisk
's ...
U.S. News & World Report
4d
Wegovy-Maker Novo Nordisk to Spend $4.1 Billion to Boost US Manufacturing
COPENHAGEN/LONDON (Reuters) - Obesity drug-maker
Novo
Nordisk
will spend $4.1 billion to build a
U.S
. facility to fill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
United States
Ozempic
Wegovy